BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 28797456)

  • 1. Rebamipide gargle in preventive management of chemo-radiotherapy induced oral mucositis.
    Chaitanya B; Pai KM; Yathiraj PH; Fernandes D; Chhaparwal Y
    Oral Oncol; 2017 Sep; 72():179-182. PubMed ID: 28797456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebamipide gargle and benzydamine gargle in prevention and management of chemo-radiotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients (randomized clinical trial).
    Elsaadany B; Anayb SM; Mashhour K; Yossif M; Zahran F
    BMC Oral Health; 2024 Jun; 24(1):645. PubMed ID: 38824583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
    Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
    BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A pilot study of rebamipide-gargle for chemoradiotherapy-induced mucositis in oral cancer patients].
    Yasuda T; Chiba H; Satomi T; Matsuo A; Kaneko T; Miyamatsu H
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1157-61. PubMed ID: 18633254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study.
    Rao S; Dinkar C; Vaishnav LK; Rao P; Rai MP; Fayad R; Baliga MS
    Integr Cancer Ther; 2014 May; 13(3):201-10. PubMed ID: 24165896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of Rebamipide Gargle against Chemotherapy-induced Oral Mucositis].
    Shinohara A; Nakamura M; Onikubo T; Nakamura K
    Yakugaku Zasshi; 2015; 135(8):937-41. PubMed ID: 26234350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The post hoc analysis comparing the severity grades of chemoradiotherapy-induced oral mucositis scored between the central and local assessors in a multicenter, randomized controlled trial of rebamipide for head and neck cancer.
    Ueno T; Zenda S; Konishi T; Yurikusa T; Shibasaki Y; Nagamoto H; Fujii M
    Int J Clin Oncol; 2019 Mar; 24(3):241-247. PubMed ID: 30426268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pilot study on clinical effects of rebamipide gargle against oral mucositis induced by fluoropyrimidines].
    Kabeya M; Ina K; Yuasa S; Kikuchi F; Tajiri C; Kato T; Hibi S; Minagawa Y; Furuta R; Kayukawa S; Kataoka T; Kawai M
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1133-6. PubMed ID: 21772097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effect of rebamipide gargle on chemoradiotherpy-induced oral mucositis in patients with oral cancer: a pilot study.
    Yasuda T; Chiba H; Satomi T; Matsuo A; Kaneko T; Chikazu D; Miyamatsu H
    J Oral Maxillofac Res; 2012; 2(4):e3. PubMed ID: 24422000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of Zataria extract mouthwash for the management of radiation-induced oral mucositis in patients: a randomized placebo-controlled double-blind study.
    Aghamohammadi A; Moslemi D; Akbari J; Ghasemi A; Azadbakht M; Asgharpour A; Hosseinimehr SJ
    Clin Oral Investig; 2018 Jul; 22(6):2263-2272. PubMed ID: 29313134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer.
    Marucci L; Farneti A; Di Ridolfi P; Pinnaro P; Pellini R; Giannarelli D; Vici P; Conte M; Landoni V; Sanguineti G
    Head Neck; 2017 Sep; 39(9):1761-1769. PubMed ID: 28560780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
    Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment.
    Lozano A; Marruecos J; Rubió J; Farré N; Gómez-Millán J; Morera R; Planas I; Lanzuela M; Vázquez-Masedo MG; Cascallar L; Giralt J; Escames G; Valentí V; Grima P; Bosser R; Tarragó C; Mesía R
    Clin Transl Oncol; 2021 Sep; 23(9):1801-1810. PubMed ID: 33738704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of head and neck cancer.
    Diaz-Sanchez RM; Pachón-Ibáñez J; Marín-Conde F; Rodríguez-Caballero Á; Gutierrez-Perez JL; Torres-Lagares D
    Med Oral Patol Oral Cir Bucal; 2015 May; 20(3):e378-85. PubMed ID: 25662553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of how to prevent mucositis induced by chemoradiotherapy].
    Tosaka C; Tajima H; Inoue T; Moya M; Kobayashi M; Miura K; Tada Y; Masubuchi T; Hushimi C; Kamata S
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1647-51. PubMed ID: 21996960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study.
    Sharma A; Rath GK; Chaudhary SP; Thakar A; Mohanti BK; Bahadur S
    Eur J Cancer; 2012 Apr; 48(6):875-81. PubMed ID: 21741230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebamipide does not interfere with the antitumor effect of radiotherapy or chemotherapy in human oral tumor-bearing nude mice.
    Shibamori M; Sato M; Uematsu N; Nakashima T; Sato A; Yamamura Y; Sasabe H; Umehara K; Sakurai K
    J Pharmacol Sci; 2015 Sep; 129(1):18-25. PubMed ID: 26320673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a randomized controlled phase III trial: efficacy of polyphenol-containing cystus® tea mouthwash solution for the reduction of mucositis in head and neck cancer patients undergoing external beam radiotherapy.
    Ebert N; Kensche A; Löck S; Hadiwikarta WW; Hänsch A; Dörr W; Krause M; Hannig C; Baumann M
    Strahlenther Onkol; 2021 Jan; 197(1):63-73. PubMed ID: 32970162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of rebamipide mouthwash therapy for radiotherapy and chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis.
    Akagi S; Fujiwara T; Nishida M; Okuda A; Nagao Y; Okuda T; Tokuda H; Takayanagi K
    J Pharm Health Care Sci; 2019; 5():16. PubMed ID: 31367460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a calcium phosphate mouth rinse on (chemo) radiation induced oral mucositis in head and neck cancer patients: a prospective study.
    Stokman MA; Burlage FR; Spijkervet FK
    Int J Dent Hyg; 2012 Aug; 10(3):175-80. PubMed ID: 23046006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.